Anzeige
Mehr »
Login
Mittwoch, 14.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Transformation! Zweistellige Millionenvereinbarung besiegelt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P723 ISIN: KYG674111011 Ticker-Symbol: 5DG 
Frankfurt
13.04.21
17:00 Uhr
2,040 Euro
-0,100
-4,67 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
OCUMENSION THERAPEUTICS Chart 1 Jahr
5-Tage-Chart
OCUMENSION THERAPEUTICS 5-Tage-Chart
RealtimeGeldBriefZeit
2,1002,18013.04.
2,0602,22013.04.

Aktuelle News zur OCUMENSION THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
OCUMENSION THERAPEUTICS Aktie jetzt für 0€ handeln
DoOcumension (01477) gets new drug application accepted1
07.04.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE III CLINICAL TRIAL OF OT-101 IN THE UNITED STATES AND THE PLANNED REAL WORLD STUDY FOR OT-101 IN CHINA-
07.04.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR OT-401 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION-
19.03.OCUMENSION-B (01477): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020-
19.03.OCUMENSION-B (01477): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION-
19.03.OCUMENSION-B (01477): CHANGE OF NON-EXECUTIVE DIRECTOR-
15.03.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT-
09.03.OCUMENSION-B (01477): DATE OF BOARD MEETING-
03.03.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT SECOND PHASE III CLINICAL TRIAL OF OT-301 APPROVED IN CHINA1
03.03.OCUMENSION-B (01477): ANNOUNCEMENT OF RESULTS FOR THE YEAR ENDED DECEMBER 31, 2020-
01.03.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT SELECTION OF THE SHARES OF THE COMPANY AS A CONSTITUENT OF CERTAIN INDEXES OF HANG SENG INDEXES COMPANY LIMITED-
23.02.Ocumension (01477) gets IND approval for clinical trial-
08.02.OCUMENSION-B (01477): VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN A PHASE III CLINICAL TRIAL OF OT-702 IN CHINA1
22.01.OCUMENSION-B (01477): NEXT DAY DISCLOSURE RETURN-
22.01.OCUMENSION-B (01477): COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE-
13.01.Ocumension (01477) to raise HK$793.8 million-
13.01.OCUMENSION-B (01477): PLACING OF EXISTING SHARES TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE-
04.01.Ocumension Therapeutics invests $15.7M in EyePoint Pharma32
04.01.Ocumension Therapeutics Invests $15.7 Mln In EyePoint Pharma10
04.01.EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics13
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1